26 March 2023

Nonclinical Evaluation Report, FOI 2839 Document 6, January 2021 and comment



See 58 page report:



See also: PFIZER CONFIDENTIAL:- RISK MANAGEMENT PLAN – AUSTRALIA-SPECIFIC ANNEX

See also: Advisory Committee on Vaccines, Meeting 18, Minutes on Item 2.1

BNT162b2 [mRNA] COVID-19 vaccine


See comment video on the first document only, as they may not have been aware of the other two listed above:


No comments: